Key Points
- CEO Erez Meltzer purchased 36,000 Nano-X Imaging shares at an average price of $0.93, investing $33,480 and becoming the direct owner of those shares.
- NNOX opened at $0.88 and remains near its 12-month low of $0.73, while the company reported a quarterly loss of $0.16 per share, negative margins and an expected full-year loss.
- Analyst opinions are mixed, producing a “Moderate Buy” consensus and an average price target of $4.00; institutional investors own 21.49% of the stock.
Nano-X Imaging Ltd. (NASDAQ:NNOX - Get Free Report) CEO Erez Meltzer purchased 36,000 shares of the business's stock in a transaction dated Monday, July 27th. The shares were purchased at an average cost of $0.93 per share, for a total transaction of $33,480.00. Following the purchase, the chief executive officer directly owned 36,000 shares of the company's stock, valued at $33,480. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Nano-X Imaging Stock Down 0.9%
Nano-X Imaging stock opened at $0.88 on Wednesday. The business's 50-day simple moving average is $1.47 and its 200 day simple moving average is $2.08. The stock has a market cap of $61.08 million, a price-to-earnings ratio of -0.56 and a beta of 1.24. Nano-X Imaging Ltd. has a 12-month low of $0.73 and a 12-month high of $5.15.
Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last announced its quarterly earnings data on Thursday, June 25th. The company reported ($0.16) earnings per share for the quarter. The firm had revenue of $4.31 million for the quarter. Nano-X Imaging had a negative return on equity of 70.96% and a negative net margin of 716.44%. As a group, sell-side analysts expect that Nano-X Imaging Ltd. will post -0.6 EPS for the current year.
Hedge Funds Weigh In On Nano-X Imaging
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Kestra Advisory Services LLC acquired a new position in shares of Nano-X Imaging during the 1st quarter worth about $26,000. Independent Financial Group LLC acquired a new stake in shares of Nano-X Imaging in the 1st quarter valued at approximately $26,000. Interchange Capital Partners LLC acquired a new stake in shares of Nano-X Imaging in the 4th quarter valued at approximately $28,000. Aristides Capital LLC bought a new position in Nano-X Imaging during the 4th quarter worth approximately $30,000. Finally, Hsbc Holdings PLC bought a new position in Nano-X Imaging during the 1st quarter worth approximately $35,000. Institutional investors own 21.49% of the company's stock.
Analyst Upgrades and Downgrades
NNOX has been the subject of a number of recent research reports. Weiss Ratings reissued a "sell (e+)" rating on shares of Nano-X Imaging in a research note on Wednesday, July 8th. Zacks Research raised shares of Nano-X Imaging from a "strong sell" rating to a "hold" rating in a research note on Monday, June 22nd. D. Boral Capital reaffirmed a "buy" rating and set a $5.00 target price on shares of Nano-X Imaging in a report on Monday, April 20th. Finally, Alliance Global Partners lowered shares of Nano-X Imaging from a "buy" rating to a "neutral" rating and lowered their target price for the stock from $5.00 to $3.00 in a report on Tuesday, July 7th. Two equities research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $4.00.
Check Out Our Latest Stock Analysis on Nano-X Imaging
Key Stories Impacting Nano-X Imaging
Here are the key news stories impacting Nano-X Imaging this week:
- Positive Sentiment: CEO Erez Meltzer purchased 36,000 NNOX shares at an average price of $0.93, investing approximately $33,480. The insider purchase may signal management confidence, although the relatively small transaction is unlikely to offset broader concerns. SEC insider ownership filing
- Neutral Sentiment: Rosen Law Firm, Portnoy Law, Robbins LLP, Pomerantz LLP, Gross Law Firm and other firms reminded investors of the pending litigation and lead-plaintiff deadline. Most of these announcements are investor solicitations rather than new operating updates, but their volume increases the visibility of the dispute. Rosen Law Firm deadline notice Pomerantz class action announcement
- Negative Sentiment: The class action alleges that Nano-X and certain officers made materially misleading statements or failed to disclose rising cash burn and operating expenses before the company recorded a $17.5 million impairment. The allegations concern securities purchased between March 31, 2025 and April 17, 2026 and have not been proven in court. SueWallSt class action notice
Nano-X Imaging Company Profile
(
Get Free Report)
Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.
The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
